(Q45221760)

11 December 2017

Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator--report of a pilot trial (English)

1 reference

11 December 2017

1 reference

1 reference

Verstraete M

1

1 reference

11 December 2017

Hess H

2

1 reference

11 December 2017

Mahler F

3

1 reference

11 December 2017

Mietaschk A

4

1 reference

11 December 2017

Roth FJ

5

1 reference

11 December 2017

Schneider E

6

1 reference

11 December 2017

Baert AL

7

1 reference

11 December 2017

Verhaeghe R

8

1 reference

11 December 2017

language of work or name

1 reference

1 June 1988

1 reference

European journal of vascular surgery

11 December 2017

1 reference

11 December 2017

2

1 reference

11 December 2017

3

1 reference

11 December 2017

155-159

1 reference

Local low-dose thrombolysis in arterial disease of the limbs

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Local low-dose thrombolytic therapy of peripheral arterial occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Local thrombolysis in femoropopliteal occlusion: early and late results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Acute pulmonary embolism treated with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2888%2980068-9

7 January 2021

10.1016/S0950-821X(88)80068-9

Identifiers

DOI

1 reference

11 December 2017

1 reference